SEATTLE / August 13, 2020
CB Insights today named Xealth, the leader in enabling digital health at scale, to its second annual Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world.
The 2020 Digital Health 150 cohort highlights startups that are reimagining the lines of the traditional healthcare experience across 12 categories, from Virtual Care Delivery and Clinical Trials, to Drug Discovery and Specialty Care. Countries represented this year include Canada, China, Israel, France, the United Kingdom, and the United States, among others.
“This year’s Digital Health 150 is our most global ever, covering the best private healthcare companies from 17 countries. Beyond geographic diversity, these companies are innovating across the entire healthcare value chain, spanning technologies that benefit pharma & biotech companies, to payers, hospitals, insurers, and more,” said CB Insights CEO Anand Sanwal. “Last year’s Digital Health 150 winners saw numerous exits and went on to raise nearly $5 billion in investor financing after being recognized. We look forward to seeing the success of this year’s class of the best in digital health.”
“As health systems experience the benefits of digital health, more care teams will turn to these tools to maintain the connection with their patients outside of in-person visits,” said Mike McSherry, CEO and co-founder of Xealth. “Patients are now getting a more consumer-like experience from their providers. Xealth works closely with health systems during this shift, helping optimize their digital health assets to achieve or surpass their clinical and operational goals. We are honored to have this value recognized by CB Insights.
Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from hundreds of applications based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty. The Mosaic Score, based on CB Insights’ algorithm, measures the overall health and growth potential of private companies to help predict a company’s momentum.
With doctors adding more tools than medications to treatment plans, including trackers, remote monitoring, digital therapeutics, patient education, and more, healthcare organizations need a way to easily incorporate them into current workflows and scale the programs. Xealth’s digital health platform enables health systems to easily integrate, deploy and scale digital health initiatives for measurable results. The company currently connects more than 30 digital health partners, including Amazon, Welldoc, Healthwise, ResMed, Babyscripts, Twistle, and SilverCloud.
At CB Insights, we believe the most complex strategic business questions are best answered with facts. We are a machine intelligence company that synthesizes, analyzes and visualizes millions of documents to give our clients fast, fact-based insights. Serving the majority of the Fortune 100, we give companies the power to make better decisions, take control of their own future, and capitalize on change.
Xealth scales digital health programs, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Through the secure Xealth platform, clinicians can find and order the right digital health tools and programs for patients direct from the EHR workflow, send these digital health orders to the patient’s email or patient portal, and then monitor activity. Xealth spun out of Providence St. Joseph Health (PSJH) in 2017, and investors include Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, and ResMed as well as Providence Ventures, UPMC and the Froedtert and Medical College of Wisconsin Health Network.
For more information, visit www.xealth.com or follow us on LinkedIn or Twitter.
© Xealth® 2021. All rights reserved.
